Skip to main content
. 2003 Jul 12;327(7406):78–79. doi: 10.1136/bmj.327.7406.78

Table 1.

Characteristics of 522 patients with chronic heart failure and preserved or impaired left ventricular systolic function. Values are means (standard deviations) unless stated otherwise

Characteristic Preserved function (n=163) Impaired function (n=359) P value
Age 62.5 (10.7) 62.3 (9.10) 0.8*
No (%) of men 117 (72) 287 (80) 0.07
NYHA class (No (%)):
I 3 (2) 7 (2) <0.001
II 119 (73) 190 (53)
III 41 (25) 162 (45)
Hypertension (No (%)) 10 (6) 11 (3) 0.2
Ischaemic heart disease (No (%)) 124 (76) 284 (79) 0.5
Myocardial infarction (No (%)) 106 (65) 237 (66) 0.9
Angiotensin converting enzyme inhibitor (No (%)) 127 (78) 294 (82) 0.4
Median (interquartile range) frusemide dose (mg) 40 (40 to 80) 80 (40 to 80) <0.001#
β blocker (No (%)) 11 (7) 22 (6) 0.9#
Digoxin (No (%)) 23 (14) 75 (21) 0.09#
Creatinine (μmol/l) 115 (39) 123 (42) <0.05*
Sodium (mmol/l) 139.9 (2.60) 139.6 (3.44) 0.3*
Potassium (mmol/l) 4.36 (0.43) 4.33 (0.51) 0.4*
Plasma glucose (mmol/l) 5.90 (2.82) 5.92 (2.31) 0.9*
Median (interquartile range) cardiothoracic ratio 0.50 (0.47 to 0.55) 0.53 (0.50 to 0.57) <0.001#
Left ventricular end systolic diameter (cm) 4.08 (0.96) 5.50 (0.98) <0.001*
Left ventricular end diastolic diameter (cm) 5.79 (1.01) 6.43 (0.95) <0.001*
Left ventricular hypertrophy (No (%)) 20 (12) 36 (10) 0.7
Median (interquartile range) heart rate (beats/min) 69 (63 to 82) 76 (66 to 89) <0.001#
Non-sustained ventricular tachycardia (No (%)) 41 (25) 158 (44) <0.001
Median (interquartile range) SDNN (ms) 115 (91 to 144) 110 (81 to 142) 0.1#
Total mortality at five years (No (%)) 41 (25) 151 (42) <0.001

NYHA=New York Heart Association.

SDNN=standard deviation of all normal R-R intervals over 24 hours.

Left ventricular hypertrophy was determined on the basis of voltage criteria.

*

Student's t test (for normally distributed data).

ϰ2 test (for categorical variables).

#

Mann-Whitney U test (for non-normally distributed data).